1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 15 JUNE 2015

Cancer Drug News 15 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - CAR-T Therapies Poised To Make An Impact
Industry Brief - Paladin To Distribute Iclusig In Canada
Industry Brief - Agios' AG-120 Gains FDA ODD For IDH1-Mutant Positive AML
Industry Brief - Janssen Initiates Rolling BLA Submission For Daratumumab In MM
Industry Trend Analysis - Subclassification To Revive Interest In EGFr Mutation-Directed Lung Cancer Treatments
Industry Brief - FDA Agrees To OncoGenex' Phase III AFFINITY Protocol Amendment
Industry Brief - Taiho/Servier Sign European TAS-102 Licensing Deal For Refractory MCRC
Industry Brief - FDA Grants ODD To Lion's LN-144 For Late-Stage Malignant Melanoma
Industry Brief - Eisai Launches Lenvima In UK For Advanced RAI-Refractory DTC
Industry Trend Analysis - Biotech Start-Ups To Continue Supporting Big Pharma Pipelines
Industry Brief - Agalimmune Licenses KODE Technology To Develop Onco-immunotherapeutics
Industry Brief - PDC*vac Gains EU ATMP Classification
Industry Trend Analysis - AstraZeneca's Combination Approach Confers Long-Term Advantages In PD-1/PD-L1 Space
Industry Brief - Merck's Keytruda Demonstrates Utility In Multiple Tumour Types
Industry Brief - BioAtla Receives USD30mn Investment From Chinese Investor Group

Table Of Contents

Cancer Drug News 15 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.